TABLE 7.
nHMF | cHMF | ||||||||
Variable | n | Median | IQR | Geometric mean | n | Median | IQR | Geometric mean | P* |
Urinary creatinine, μmol/L | |||||||||
D1 | 63 | 1300.0 | 785.5–1685.5 | 1224.7 | 69 | 1105.0 | 900.0–1500.0 | 1182.3 | |
D21 | 57 | 1030.0 | 660.0–1609.0 | 1000.3 | 55 | 854.0 | 618.0–1273.0 | 900.8 | 0.447 |
Serum hemoglobin, mmol/L | |||||||||
D1 | 68 | 2.08 | 1.84–2.29 | 2.14 | 72 | 2.02 | 1.84–2.26 | 2.18 | |
D21 | 63 | 1.71 | 1.56–1.91 | 1.83 | 66 | 1.69 | 1.50–1.98 | 1.76 | 0.936 |
Serum hematocrit, % | |||||||||
D1 | 68 | 0.40 | 0.35–0.43 | 0.39 | 72 | 0.39 | 0.35–0.43 | 0.38 | |
D21 | 63 | 0.32 | 0.29–0.38 | 0.33 | 66 | 0.33 | 0.28–0.38 | 0.33 | 0.805 |
Urinary sodium, mmol/L | |||||||||
D1 | 66 | 37.0 | 23.3–57.3 | 37.5 | 69 | 32.0 | 19.4–54.0 | 31.2 | |
D21 | 59 | 34.0 | 21.1–48.0 | 33.3 | 56 | 23.0 | 14.3–36.4 | 24.0 | 0.037 |
Urinary potassium, mmol/L | |||||||||
D1 | 66 | 25.9 | 13.6–37.0 | 23.6 | 69 | 21.8 | 15.0–32.2 | 20.0 | |
D21 | 59 | 30.0 | 16.9–45.0 | 27.6 | 57 | 22.9 | 16.9–30.4 | 22.8 | 0.040 |
Urinary chloride, mmol/L | |||||||||
D1 | 60 | 37.0 | 26.3–60.0 | 40.2 | 67 | 33.0 | 20.5–55.0 | 34.2 | |
D21 | 54 | 31.0 | 17.8–43.8 | 30.7 | 55 | 26.0 | 18.0–39.5 | 27.8 | 0.558 |
cHMF = control human milk fortifier; D1 = study day 1; D21 = study day 21; IQR = interquartile range; nHMF = new human milk fortifier .
*D21 geometric mean values were log-transformed and analyzed using analysis of covariance (adjusting for the relevant biochemical measure at D1, sex, and center).